Abstract

In utero exposure to maternal immune activation (MIA) is an environmental risk factor for neurodevelopmental and neuropsychiatric disorders. Animal models provide an opportunity to identify mechanisms driving neuropathology associated with MIA. We performed time course transcriptional profiling of mouse cortical development following induced MIA via poly(I:C) injection at E12.5. MIA-driven transcriptional changes were validated via protein analysis, and parallel perturbations to cortical neuroanatomy were identified via imaging. MIA-induced acute upregulation of genes associated with hypoxia, immune signaling, and angiogenesis, by six hours following exposure. This acute response was followed by changes in proliferation, neuronal and glial specification, and cortical lamination that emerged at E14.5 and peaked at E17.5. Decreased numbers of proliferative cells in germinal zones and alterations in neuronal and glial populations were identified in the MIA-exposed cortex. Overall, paired transcriptomic and neuroanatomical characterization revealed a sequence of perturbations to corticogenesis driven by mid-gestational MIA.

Data availability

Sequencing data (raw and gene-count data for RNA-seq) have been deposited in GEO under accession number GSE166376. Available at: https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE166376Data analysis code is available at: https://github.com/NordNeurogenomicsLab/Publications/tree/master/Canales_eLife_2021Detailed DE analysis are included in the manuscript and supporting files (Supplementary files 1-15) and can be visualized using our interactive online browser at: https://nordlab.shinyapps.io/mia_browser/.

The following data sets were generated

Article and author information

Author details

  1. Cesar P Canales

    Center for Neuroscience, University of California, Davis, Davis, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-2505-8367
  2. Myka L Estes

    Center for Neuroscience, University of California, Davis, Davis, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Karol Cichewicz

    Center for Neuroscience, University of California, Davis, Davis, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Kartik Angara

    Department of Pediatrics & Human Development, Michigan State University, Grand Rapids, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. John Paul Aboubechara

    Center for Neuroscience, University of California, Davis, Davis, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Scott Cameron

    Center for Neuroscience, University of California, Davis, Davis, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. Kathryn Prendergast

    Center for Neuroscience, University of California, Davis, Davis, United States
    Competing interests
    The authors declare that no competing interests exist.
  8. Linda Su-Feher

    Center for Neuroscience, University of California, Davis, Davis, United States
    Competing interests
    The authors declare that no competing interests exist.
  9. Iva Zdilar

    Center for Neuroscience, University of California, Davis, Davis, United States
    Competing interests
    The authors declare that no competing interests exist.
  10. Ellie J Kreun

    Center for Neuroscience, University of California, Davis, Davis, United States
    Competing interests
    The authors declare that no competing interests exist.
  11. Emma C Connolly

    Center for Neuroscience, University of California, Davis, Davis, United States
    Competing interests
    The authors declare that no competing interests exist.
  12. Jin Myeong Seo

    Center for Neuroscience, University of California, Davis, Davis, United States
    Competing interests
    The authors declare that no competing interests exist.
  13. Jack B Goon

    Center for Neuroscience, University of California, Davis, Davis, United States
    Competing interests
    The authors declare that no competing interests exist.
  14. Kathleen Farrelly

    Center for Neuroscience, University of California, Davis, Davis, United States
    Competing interests
    The authors declare that no competing interests exist.
  15. Tyler W Stradleigh

    Center for Neuroscience, University of California, Davis, Davis, United States
    Competing interests
    The authors declare that no competing interests exist.
  16. Deborah van der List

    Department of Physiology and Membrane Biology, University of California, Davis, Davis, United States
    Competing interests
    The authors declare that no competing interests exist.
  17. Lory Haapanen

    Div. of Rheumatology/Allergy and Clin. Immunol, University of California, Davis, Davis, United States
    Competing interests
    The authors declare that no competing interests exist.
  18. Judy Van de Water

    Div. of Rheumatology/Allergy and Clin. Immunol, University of California, Davis, Davis, United States
    Competing interests
    The authors declare that no competing interests exist.
  19. Daniel Vogt

    Department of Pediatrics & Human Development, Michigan State University, Grand Rapids, United States
    Competing interests
    The authors declare that no competing interests exist.
  20. Kim McAllister

    Center for Neuroscience, University of California, Davis, Davis, United States
    For correspondence
    kmcallister@ucdavis.edu
    Competing interests
    The authors declare that no competing interests exist.
  21. Alex S Nord

    Psychiatry and Behavioral Sciences, University of California, Davis, Davis, United States
    For correspondence
    asnord@ucdavis.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4259-7514

Funding

National Institute of Mental Health (2T32MH073124-16)

  • Cesar P Canales

National Institute of Mental Health (5R21MH116681-02)

  • Kim McAllister
  • Alex S Nord

Brain Research Foundation

  • Alex S Nord

The UCD Clinical Translational Science Center

  • Kim McAllister
  • Alex S Nord

National Institute of General Medical Sciences (GM119831)

  • Alex S Nord

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: This study was conducted in compliance with NIH guidelines and approved protocols from the University of California Davis Animal Care and Use Committee (IACUC) protocol #20229

Copyright

© 2021, Canales et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,682
    views
  • 345
    downloads
  • 23
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Cesar P Canales
  2. Myka L Estes
  3. Karol Cichewicz
  4. Kartik Angara
  5. John Paul Aboubechara
  6. Scott Cameron
  7. Kathryn Prendergast
  8. Linda Su-Feher
  9. Iva Zdilar
  10. Ellie J Kreun
  11. Emma C Connolly
  12. Jin Myeong Seo
  13. Jack B Goon
  14. Kathleen Farrelly
  15. Tyler W Stradleigh
  16. Deborah van der List
  17. Lory Haapanen
  18. Judy Van de Water
  19. Daniel Vogt
  20. Kim McAllister
  21. Alex S Nord
(2021)
Sequential perturbations to mouse corticogenesis following in utero maternal immune activation
eLife 10:e60100.
https://doi.org/10.7554/eLife.60100

Share this article

https://doi.org/10.7554/eLife.60100

Further reading

    1. Genetics and Genomics
    2. Microbiology and Infectious Disease
    Dániel Molnár, Éva Viola Surányi ... Judit Toth
    Research Article

    The sustained success of Mycobacterium tuberculosis as a pathogen arises from its ability to persist within macrophages for extended periods and its limited responsiveness to antibiotics. Furthermore, the high incidence of resistance to the few available antituberculosis drugs is a significant concern, especially since the driving forces of the emergence of drug resistance are not clear. Drug-resistant strains of Mycobacterium tuberculosis can emerge through de novo mutations, however, mycobacterial mutation rates are low. To unravel the effects of antibiotic pressure on genome stability, we determined the genetic variability, phenotypic tolerance, DNA repair system activation, and dNTP pool upon treatment with current antibiotics using Mycobacterium smegmatis. Whole-genome sequencing revealed no significant increase in mutation rates after prolonged exposure to first-line antibiotics. However, the phenotypic fluctuation assay indicated rapid adaptation to antibiotics mediated by non-genetic factors. The upregulation of DNA repair genes, measured using qPCR, suggests that genomic integrity may be maintained through the activation of specific DNA repair pathways. Our results, indicating that antibiotic exposure does not result in de novo adaptive mutagenesis under laboratory conditions, do not lend support to the model suggesting antibiotic resistance development through drug pressure-induced microevolution.

    1. Computational and Systems Biology
    2. Genetics and Genomics
    Sanjarbek Hudaiberdiev, Ivan Ovcharenko
    Research Article

    Enhancers and promoters are classically considered to be bound by a small set of transcription factors (TFs) in a sequence-specific manner. This assumption has come under increasing skepticism as the datasets of ChIP-seq assays of TFs have expanded. In particular, high-occupancy target (HOT) loci attract hundreds of TFs with often no detectable correlation between ChIP-seq peaks and DNA-binding motif presence. Here, we used a set of 1003 TF ChIP-seq datasets (HepG2, K562, H1) to analyze the patterns of ChIP-seq peak co-occurrence in combination with functional genomics datasets. We identified 43,891 HOT loci forming at the promoter (53%) and enhancer (47%) regions. HOT promoters regulate housekeeping genes, whereas HOT enhancers are involved in tissue-specific process regulation. HOT loci form the foundation of human super-enhancers and evolve under strong negative selection, with some of these loci being located in ultraconserved regions. Sequence-based classification analysis of HOT loci suggested that their formation is driven by the sequence features, and the density of mapped ChIP-seq peaks across TF-bound loci correlates with sequence features and the expression level of flanking genes. Based on the affinities to bind to promoters and enhancers we detected five distinct clusters of TFs that form the core of the HOT loci. We report an abundance of HOT loci in the human genome and a commitment of 51% of all TF ChIP-seq binding events to HOT locus formation thus challenging the classical model of enhancer activity and propose a model of HOT locus formation based on the existence of large transcriptional condensates.